Antibodies Assay Kits Bap1 Antibody Biology Cells Brd4 Antibody Equipments Exosomes Fto Antibody Gels Nse Antibody Olig2 Antibody Panel Particles PCR Test Kits Tgf Alpha Antibody Vector & Virus
MicroRNAs in Genetic Etiology of Human Diseases
Since their first discovery greater than 20 years in the past, miRNAs have been topic to deliberate analysis and evaluation for revealing their physiological or pathological involvement. Regulatory roles of miRNAs in sign transduction, gene expression, and mobile processes in improvement, differentiation, proliferation, apoptosis, and homeostasis additionally suggest their vital function in illness pathogenesis.
Their roles in most cancers, neurodegenerative ailments, and different systemic ailments have been studied broadly. In these regulatory pathways, their mutations and goal sequence variations play vital roles to find out their purposeful repertoire. On this chapter, we summarize research that investigated the function of mutations, polymorphisms, and different variations of miRNAs in respect to pathological processes.
INFIMA leverages multi-omics mannequin organism information to establish effector genes of human GWAS variants
Genome-wide affiliation research reveal many non-coding variants related to advanced traits. Nonetheless, mannequin organism research largely stay as an untapped useful resource for unveiling the effector genes of non-coding variants.
We develop INFIMA, Integrative Wonderful-Mapping, to pinpoint causal SNPs for range outbred (DO) mice eQTL by integrating founder mice multi-omics information together with ATAC-seq, RNA-seq, footprinting, and in silico mutation evaluation.
We show INFIMA’s superior efficiency in comparison with alternate options with human and mouse chromatin conformation seize datasets. We apply INFIMA to establish novel effector genes for GWAS variants related to diabetes.
Discrete genetic loci in human intestine Bacteroides thetaiotaomicron confer pectin metabolism
Though the polysaccharide utilization loci (PULs) activated by pectin have been outlined, because of the advanced of side-chain construction, the degradative mechanisms nonetheless stay imprecise. Thus, we hypothesize that there might produce other particular PULs to focus on pectin. Right here, we characterize loci-encoded proteins expressed by Bacteroides thetaiotaomicron (BT) which might be concerned within the pectin capturing, importation, de-branching and degradation into monosaccharides.
Completely, 4 PULs comprise ten enzymes and 4 glycan binding proteins which together with a novel floor enzyme and a floor glycan binding protein are recognized. Notably, PUL2 and PUL3 haven’t been reported to this point.
Additional, we present that the degradation merchandise assist the expansion of different Bacteroides spp. and probiotics. As well as, genes concerned on this course of are conservative in different Bacteroides spp. Our outcomes additional spotlight the contribution of Bacteroides spp. to metabolism the pectic community.
Transcriptomic evaluation of human brains with Alzheimer’s illness reveals the altered expression of synaptic genes linked to cognitive deficits
Alzheimer’s illness is a progressive neurodegenerative dysfunction related to reminiscence loss and impaired govt operate. The molecular underpinnings inflicting cognitive deficits in Alzheimer’s illness are loosely understood. Right here, we carried out cross-study large-scale transcriptomic analyses of postmortem prefrontal cortex derived from Alzheimer’s illness sufferers to disclose the function of aberrant gene expression on this illness.
We recognized that probably the most outstanding modifications in prefrontal cortex of Alzheimer’s illness people was the downregulation of genes in excitatory and inhibitory neurons which might be related to synaptic features, significantly the SNARE-binding advanced, which is important for vesicle docking and neurotransmitter launch.
Evaluating genomic information of Alzheimer’s illness with proteomic information of cognitive trajectory, we discovered that most of the misplaced synaptic genes in Alzheimer’s illness encode hub proteins whose elevated abundance is required for cognitive stability. This examine has revealed potential molecular targets for therapeutic intervention of cognitive decline related to Alzheimer’s illness.
Uncommon Genetic Issues: Novel Therapy Methods and Insights Into Human Biology
The final decade has seen a dramatic enhance in progressive concepts for the therapy of genetic problems for which no healing therapies exist. Gene and protein substitute therapies stand out as novel approaches to deal with a choose group of those ailments, equivalent to sure tissue fragility problems.
Additional, the arrival of stem cell approaches, equivalent to induced pluripotent stem cells (iPSC) know-how, has led to the event of latest strategies of making substitute tissues for regenerative medication. This coincided with the invention of genome modifying strategies, which permit for the correction of disease-causing mutations.
The end result of those discoveries means that new and progressive therapies for monogenetic problems affecting single organs or tissues are on the horizon. Challenges stay, nevertheless, particularly with ailments that concurrently have an effect on a number of tissues and organs throughout improvement. Examples of this group of ailments embrace ectodermal dysplasias, genetic problems affecting the event of tissues and organs such because the pores and skin, cornea, and epithelial appendages.
Gene or protein substitute methods are unlikely to achieve success in addressing the multiorgan phenotype of those ailments. As an alternative, we imagine {that a} simpler method might be to concentrate on correcting phenotypes in essentially the most severely affected tissues. This might embrace the technology of substitute tissues or the identification of pharmaceutical compounds that right illness pathways in particular tissues.
Meta-Evaluation-Assisted Detection of Gravity-Delicate Genes in Human Vascular Endothelial Cells
Gravity impacts the operate and upkeep of organs, equivalent to bones, muscular tissues, and the guts. A number of research have used DNA microarrays to establish genes with altered expressions in response to gravity. Nonetheless, it’s technically difficult to mix the outcomes from varied microarray datasets due to their totally different information constructions.
We hypothesized that it’s attainable to establish frequent modifications in gene expression from the DNA microarray datasets obtained underneath varied situations and strategies. On this examine, we grouped homologous genes to carry out a meta-analysis of a number of vascular endothelial cell and skeletal muscle datasets. In response to the t-distributed stochastic neighbor embedding (t-SNE) evaluation, the modifications within the gene expression sample in vascular endothelial cells fashioned particular clusters.
We additionally recognized candidate genes in endothelial cells that responded to gravity. Additional, we uncovered human umbilical vein endothelial cells (HUVEC) to simulated microgravity (SMG) utilizing a clinostat and measured the expression ranges of the candidate genes.
Recombinant Human rhinovirus A serotype 89 Genome polyprotein VP1 |
|||
| MBS1245807-05mgYeast | MyBiosource | 0.5mg(Yeast) | EUR 1065 |
Recombinant Human rhinovirus A serotype 89 Genome polyprotein VP1 |
|||
| MBS9421040-002mg | MyBiosource | 0.02mg | EUR 285 |
Recombinant Human rhinovirus A serotype 89 Genome polyprotein VP1 |
|||
| MBS9421040-01mg | MyBiosource | 0.1mg | EUR 470 |
Recombinant Human rhinovirus A serotype 89 Genome polyprotein VP1 |
|||
| MBS9421040-1mg | MyBiosource | 1mg | EUR 1785 |
Recombinant Human rhinovirus A serotype 89 Genome polyprotein VP1 |
|||
| MBS9421040-5x1mg | MyBiosource | 5x1mg | EUR 7885 |
Recombinant Human rhinovirus 1A Genome polyprotein, partial |
|||
| CSB-EP326367HQA | Cusabio | 11613 mg | Ask for price |
Recombinant Human rhinovirus 1A Genome polyprotein, partial |
|||
| CSB-EP326367HQA-100ug | Cusabio | 100ug | Ask for price |
|
Description: 571-857aa |
|||
Recombinant Human rhinovirus 1A Genome polyprotein, partial |
|||
| CSB-EP326367HQA-1mg | Cusabio | 1mg | Ask for price |
|
Description: 571-857aa |
|||
Recombinant Human rhinovirus 1A Genome polyprotein, partial |
|||
| CSB-EP326367HQA-20ug | Cusabio | 20ug | Ask for price |
|
Description: 571-857aa |
|||
Recombinant Human rhinovirus 1A Genome polyprotein,partial |
|||
| AP72911 | SAB | each | Ask for price |
Recombinant Human rhinovirus 1A Genome polyprotein, partial |
|||
| CSB-YP326367HQA | Cusabio | 6222 mg | Ask for price |
Recombinant Human rhinovirus 1A Genome polyprotein, partial |
|||
| CSB-YP326367HQA-20ug | Cusabio | 20ug | Ask for price |
|
Description: 571-857aa |
|||
Recombinant Human rhinovirus 1A Genome polyprotein, partial |
|||
| MBS1220686-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 375 |
Recombinant Human rhinovirus 1A Genome polyprotein, partial |
|||
| MBS1220686-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 275 |
Recombinant Human rhinovirus 1A Genome polyprotein, partial |
|||
| MBS1220686-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 640 |
Recombinant Human rhinovirus 1A Genome polyprotein, partial |
|||
| MBS1220686-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 450 |
Recombinant Human rhinovirus 1A Genome polyprotein, partial |
|||
| MBS1220686-05mgYeast | MyBiosource | 0.5mg(Yeast) | EUR 1065 |
Recombinant Human rhinovirus 1A Genome polyprotein,partial |
|||
| RPC25135-100ug | Biomatik Corporation | 100ug | EUR 573.1 |
Recombinant Human rhinovirus 1A Genome polyprotein,partial |
|||
| RPC25135-20ug | Biomatik Corporation | 20ug | EUR 288.8 |
Human rhinovirus 1A Genome polyprotein |
|||
| 1-CSB-YP326367HQA | Cusabio |
|
|
|
Description: Recombinant Human rhinovirus 1A Genome polyprotein,partial expressed in Yeast |
|||
Recombinant Human rhinovirus 14 Genome polyprotein |
|||
| MBS1158398-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1205 |
Recombinant Human rhinovirus 14 Genome polyprotein |
|||
| MBS1158398-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 860 |
Recombinant Human rhinovirus 14 Genome polyprotein |
|||
| MBS1158398-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 995 |
Recombinant Human rhinovirus 14 Genome polyprotein |
|||
| MBS1158398-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1035 |
Recombinant Human rhinovirus 14 Genome polyprotein |
|||
| MBS1158398-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1135 |
Recombinant Human rhinovirus 1B Genome polyprotein |
|||
| MBS1154102-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1205 |
Recombinant Human rhinovirus 1B Genome polyprotein |
|||
| MBS1154102-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 855 |
Recombinant Human rhinovirus 1B Genome polyprotein |
|||
| MBS1154102-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 995 |
Recombinant Human rhinovirus 1B Genome polyprotein |
|||
| MBS1154102-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1030 |
Recombinant Human rhinovirus 1B Genome polyprotein |
|||
| MBS1154102-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1130 |
Recombinant Human rhinovirus 16 Genome polyprotein |
|||
| MBS1325019-005mgBaculovirus | MyBiosource | 0.05mg(Baculovirus) | EUR 1120 |
Recombinant Human rhinovirus 16 Genome polyprotein |
|||
| MBS1325019-005mgEColi | MyBiosource | 0.05mg(E-Coli) | EUR 860 |
Recombinant Human rhinovirus 16 Genome polyprotein |
|||
| MBS1325019-005mgYeast | MyBiosource | 0.05mg(Yeast) | EUR 995 |
Recombinant Human rhinovirus 16 Genome polyprotein |
|||
| MBS1325019-02mgEColi | MyBiosource | 0.2mg(E-Coli) | EUR 1120 |
Recombinant Human rhinovirus 16 Genome polyprotein |
|||
| MBS1325019-05mgEColi | MyBiosource | 0.5mg(E-Coli) | EUR 1225 |
Recombinant Human rhinovirus 3 Genome polyprotein |
|||
| MBS1326793-005mgBaculovirus | MyBiosource | 0.05mg(Baculovirus) | EUR 1125 |
Recombinant Human rhinovirus 3 Genome polyprotein |
|||
| MBS1326793-005mgEColi | MyBiosource | 0.05mg(E-Coli) | EUR 860 |
Recombinant Human rhinovirus 3 Genome polyprotein |
|||
| MBS1326793-005mgYeast | MyBiosource | 0.05mg(Yeast) | EUR 995 |
Recombinant Human rhinovirus 3 Genome polyprotein |
|||
| MBS1326793-02mgEColi | MyBiosource | 0.2mg(E-Coli) | EUR 1120 |
Recombinant Human rhinovirus 3 Genome polyprotein |
|||
| MBS1326793-05mgEColi | MyBiosource | 0.5mg(E-Coli) | EUR 1225 |
Recombinant Human rhinovirus 2 Genome polyprotein |
|||
| MBS1030888-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1205 |
Recombinant Human rhinovirus 2 Genome polyprotein |
|||
| MBS1030888-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 860 |
Recombinant Human rhinovirus 2 Genome polyprotein |
|||
| MBS1030888-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 995 |
Recombinant Human rhinovirus 2 Genome polyprotein |
|||
| MBS1030888-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 1030 |
Recombinant Human rhinovirus 2 Genome polyprotein |
|||
| MBS1030888-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 1135 |
Recombinant Human rhinovirus 1B Genome polyprotein, partial |
|||
| CSB-EP320160HQB | Cusabio | 10401 mg | Ask for price |
Recombinant Human rhinovirus 1B Genome polyprotein, partial |
|||
| CSB-EP320160HQB-100ug | Cusabio | 100ug | Ask for price |
|
Description: 2-332aa |
|||
Recombinant Human rhinovirus 1B Genome polyprotein, partial |
|||
| CSB-EP320160HQB-1mg | Cusabio | 1mg | Ask for price |
|
Description: 2-332aa |
|||
Recombinant Human rhinovirus 1B Genome polyprotein, partial |
|||
| CSB-EP320160HQB-20ug | Cusabio | 20ug | Ask for price |
|
Description: 2-332aa |
|||
Recombinant Human rhinovirus A serotype 89 Genome polyprotein |
|||
| MBS9422687-002mg | MyBiosource | 0.02mg | EUR 320 |
Recombinant Human rhinovirus A serotype 89 Genome polyprotein |
|||
| MBS9422687-01mg | MyBiosource | 0.1mg | EUR 540 |
Recombinant Human rhinovirus A serotype 89 Genome polyprotein |
|||
| MBS9422687-05mg | MyBiosource | 0.5mg | EUR 1360 |
Recombinant Human rhinovirus A serotype 89 Genome polyprotein |
|||
| MBS9422687-5x05mg | MyBiosource | 5x0.5mg | EUR 5965 |
Recombinant Human rhinovirus A serotype 89 Genome polyprotein, partial |
|||
| CSB-EP362073HQD | Cusabio | 3389 mg | Ask for price |
Recombinant Human rhinovirus A serotype 89 Genome polyprotein, partial |
|||
| CSB-EP362073HQD-20ug | Cusabio | 20ug | Ask for price |
|
Description: 575-866aa |
|||
Recombinant Human rhinovirus A serotype 89 Genome polyprotein, partial |
|||
| CSB-EP362073HQDb0 | Cusabio | 3390 mg | Ask for price |
Recombinant Human rhinovirus A serotype 89 Genome polyprotein, partial |
|||
| CSB-EP362073HQDb0-20ug | Cusabio | 20ug | Ask for price |
|
Description: 575-866aa |
|||
Recombinant Human rhinovirus A serotype 89 Genome polyprotein,partial |
|||
| AP71163 | SAB | 1mg | EUR 1978 |
Recombinant Human rhinovirus A serotype 89 Genome polyprotein,partial |
|||
| AP72984 | SAB | each | Ask for price |
Recombinant Human rhinovirus A serotype 89 Genome polyprotein,partial |
|||
| AP77542 | SAB | 1mg | EUR 1978 |
Recombinant Human rhinovirus A serotype 89 Genome polyprotein, partial |
|||
| CSB-YP362073HQD | Cusabio | 6387 mg | Ask for price |
Recombinant Human rhinovirus A serotype 89 Genome polyprotein, partial |
|||
| CSB-YP362073HQD-20ug | Cusabio | 20ug | Ask for price |
|
Description: 575-866aa |
|||
Recombinant Human rhinovirus A serotype 89 Genome polyprotein,partial |
|||
| RPC22779-100ug | Biomatik Corporation | 100ug | EUR 460.9 |
Recombinant Human rhinovirus A serotype 89 Genome polyprotein,partial |
|||
| RPC22779-1mg | Biomatik Corporation | 1mg | EUR 2237.8 |
Recombinant Human rhinovirus A serotype 89 Genome polyprotein,partial |
|||
| RPC22779-20ug | Biomatik Corporation | 20ug | EUR 258.7 |
Human rhinovirus A serotype 89 Genome polyprotein |
|||
| 1-CSB-EP362073HQD | Cusabio |
|
|
|
Description: Recombinant Human rhinovirus A serotype 89 Genome polyprotein,partial expressed in E.coli |
|||
Human rhinovirus A serotype 89 Genome polyprotein |
|||
| 1-CSB-EP362073HQDb0 | Cusabio |
|
|
|
Description: Recombinant Human rhinovirus A serotype 89 Genome polyprotein,partial expressed in E.coli |
|||
Human rhinovirus A serotype 89 Genome polyprotein |
|||
| 1-CSB-YP362073HQD | Cusabio |
|
|
|
Description: Recombinant Human rhinovirus A serotype 89 Genome polyprotein,partial expressed in Yeast |
|||
Recombinant Human rhinovirus A serotype 89 Genome polyprotein, partial, Biotinylated |
|||
| CSB-EP362073HQD-B | Cusabio | 7058 mg | Ask for price |
Recombinant Human rhinovirus A serotype 89 Genome polyprotein, partial, Biotinylated |
|||
| CSB-EP362073HQD-B-100ug | Cusabio | 100ug | Ask for price |
|
Description: 575-866aa |
|||
Recombinant Human rhinovirus A serotype 89 Genome polyprotein, partial, Biotinylated |
|||
| CSB-EP362073HQD-B-1mg | Cusabio | 1mg | Ask for price |
|
Description: 575-866aa |
|||
Recombinant Human rhinovirus A serotype 89 Genome polyprotein, partial, Biotinylated |
|||
| CSB-EP362073HQD-B-20ug | Cusabio | 20ug | Ask for price |
|
Description: 575-866aa |
|||
Recombinant Human rhinovirus A serotype 89 Genome polyprotein, partial, Biotinylated |
|||
| MBS7137014-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 255 |
Recombinant Human rhinovirus A serotype 89 Genome polyprotein, partial, Biotinylated |
|||
| MBS7137014-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 405 |
Recombinant Human rhinovirus A serotype 89 Genome polyprotein, partial, Biotinylated |
|||
| MBS7137014-1mgEColi | MyBiosource | 1mg(E-Coli) | EUR 1425 |
Recombinant Human rhinovirus A serotype 89 Genome polyprotein, partial, Biotinylated |
|||
| MBS7137014-5x1mgEColi | MyBiosource | 5x1mg(E-Coli) | EUR 6215 |
Recombinant Human rhinovirus A serotype 89 Genome polyprotein,partial,Biotinylated |
|||
| RPC27677-100ug | Biomatik Corporation | 100ug | EUR 614.3 |
Recombinant Human rhinovirus A serotype 89 Genome polyprotein,partial,Biotinylated |
|||
| RPC27677-1mg | Biomatik Corporation | 1mg | EUR 2373.6 |
Recombinant Human rhinovirus A serotype 89 Genome polyprotein,partial,Biotinylated |
|||
| RPC27677-20ug | Biomatik Corporation | 20ug | EUR 468 |
Rhinovirus A serotype 89 Genome polyprotein Antibody |
|||
| abx109372-100l | Abbexa | 100 µl | EUR 162.5 |
Rhinovirus A serotype 89 Genome polyprotein Antibody |
|||
| 20-abx109372 | Abbexa |
|
|
Rhinovirus A serotype 89 Genome polyprotein Antibody (HRP) |
|||
| abx108723-100g | Abbexa | 100 µg | EUR 362.5 |
Rhinovirus A serotype 89 Genome polyprotein Antibody (HRP) |
|||
| 20-abx108723 | Abbexa |
|
|
Rhinovirus A serotype 89 Genome polyprotein Antibody (HRP) |
|||
| abx108723-20g | Abbexa | 20 µg | EUR 162.5 |
Rhinovirus A serotype 89 Genome polyprotein Antibody (HRP) |
|||
| abx108723-50g | Abbexa | 50 µg | EUR 250 |
Rhinovirus A serotype 89 Genome polyprotein Antibody (FITC) |
|||
| abx107303-100g | Abbexa | 100 µg | EUR 362.5 |
Rhinovirus A serotype 89 Genome polyprotein Antibody (FITC) |
|||
| 20-abx107303 | Abbexa |
|
|
Rhinovirus A serotype 89 Genome polyprotein Antibody (FITC) |
|||
| abx107303-20g | Abbexa | 20 µg | EUR 162.5 |
Rhinovirus A serotype 89 Genome polyprotein Antibody (FITC) |
|||
| abx107303-50g | Abbexa | 50 µg | EUR 250 |
Rabbit anti-Human rhinovirus A serotype 89 Genome polyprotein polyclonal Antibody |
|||
| MBS1493993-005mg | MyBiosource | 0.05mg | EUR 190 |
Rabbit anti-Human rhinovirus A serotype 89 Genome polyprotein polyclonal Antibody |
|||
| MBS1493993-01mg | MyBiosource | 0.1mg | EUR 270 |
Rabbit anti-Human rhinovirus A serotype 89 Genome polyprotein polyclonal Antibody |
|||
| MBS1493993-5x01mg | MyBiosource | 5x0.1mg | EUR 1205 |
Rabbit anti-Human rhinovirus A serotype 89 Genome polyprotein polyclonal Antibody, FITC |
|||
| MBS1492262-005mg | MyBiosource | 0.05mg | EUR 190 |
Rabbit anti-Human rhinovirus A serotype 89 Genome polyprotein polyclonal Antibody, FITC |
|||
| MBS1492262-01mg | MyBiosource | 0.1mg | EUR 270 |
Rabbit anti-Human rhinovirus A serotype 89 Genome polyprotein polyclonal Antibody, FITC |
|||
| MBS1492262-5x01mg | MyBiosource | 5x0.1mg | EUR 1205 |
Rabbit anti-Human rhinovirus A serotype 89 Genome polyprotein polyclonal Antibody, HRP conjugated |
|||
| MBS1492051-005mg | MyBiosource | 0.05mg | EUR 190 |
Rabbit anti-Human rhinovirus A serotype 89 Genome polyprotein polyclonal Antibody, HRP conjugated |
|||
| MBS1492051-01mg | MyBiosource | 0.1mg | EUR 270 |
Rabbit anti-Human rhinovirus A serotype 89 Genome polyprotein polyclonal Antibody, HRP conjugated |
|||
| MBS1492051-5x01mg | MyBiosource | 5x0.1mg | EUR 1205 |
Rabbit anti-Human rhinovirus A serotype 89 Genome polyprotein polyclonal Antibody, Biotin conjugated |
|||
| MBS1496260-005mg | MyBiosource | 0.05mg | EUR 190 |
Rabbit anti-Human rhinovirus A serotype 89 Genome polyprotein polyclonal Antibody, Biotin conjugated |
|||
| MBS1496260-01mg | MyBiosource | 0.1mg | EUR 270 |
Rabbit anti-Human rhinovirus A serotype 89 Genome polyprotein polyclonal Antibody, Biotin conjugated |
|||
| MBS1496260-5x01mg | MyBiosource | 5x0.1mg | EUR 1205 |
Recombinant human Genome polyprotein |
|||
| MBS960928-005mg | MyBiosource | 0.05mg | EUR 695 |
Recombinant human Genome polyprotein |
|||
| MBS960928-02mg | MyBiosource | 0.2mg | EUR 905 |
Recombinant human Genome polyprotein |
|||
| MBS960928-05mg | MyBiosource | 0.5mg | EUR 990 |
Recombinant human Genome polyprotein |
|||
| MBS960928-1mg | MyBiosource | 1mg | EUR 1355 |
Recombinant Genome polyprotein |
|||
| MBS1236293-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1045 |
Recombinant Genome polyprotein |
|||
| MBS1236293-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 625 |
Recombinant Genome polyprotein |
|||
| MBS1236293-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 800 |
Recombinant Genome polyprotein |
|||
| MBS1236293-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 725 |
Recombinant Genome polyprotein |
|||
| MBS1236293-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 935 |
Recombinant Genome polyprotein |
|||
| MBS1141323-005mgBaculovirus | MyBiosource | 0.05mg(Baculovirus) | EUR 875 |
Recombinant Genome polyprotein |
|||
| MBS1141323-005mgEColi | MyBiosource | 0.05mg(E-Coli) | EUR 490 |
Recombinant Genome polyprotein |
|||
| MBS1141323-005mgYeast | MyBiosource | 0.05mg(Yeast) | EUR 690 |
Recombinant Genome polyprotein |
|||
| MBS1141323-02mgEColi | MyBiosource | 0.2mg(E-Coli) | EUR 640 |
Recombinant Genome polyprotein |
|||
| MBS1141323-05mgEColi | MyBiosource | 0.5mg(E-Coli) | EUR 695 |
Recombinant Genome polyprotein |
|||
| MBS1257473-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 990 |
Recombinant Genome polyprotein |
|||
| MBS1257473-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 555 |
Recombinant Genome polyprotein |
|||
| MBS1257473-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 745 |
Recombinant Genome polyprotein |
|||
| MBS1257473-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 665 |
Recombinant Genome polyprotein |
|||
| MBS1257473-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 870 |
Recombinant Genome polyprotein |
|||
| MBS1068339-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 990 |
Recombinant Genome polyprotein |
|||
| MBS1068339-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 555 |
Recombinant Genome polyprotein |
|||
| MBS1068339-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 745 |
Recombinant Genome polyprotein |
|||
| MBS1068339-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 665 |
Recombinant Genome polyprotein |
|||
| MBS1068339-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 870 |
Recombinant Genome polyprotein |
|||
| MBS1040920-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1045 |
Recombinant Genome polyprotein |
|||
| MBS1040920-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 620 |
Recombinant Genome polyprotein |
|||
| MBS1040920-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 795 |
Recombinant Genome polyprotein |
|||
| MBS1040920-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 720 |
Gene expression evaluation utilizing qRT-PCR revealed that the expression degree of the prostaglandin (PG) transporter gene SLCO2A1 decreased in response to microgravity, in keeping with the meta-analysis of microarray datasets. Moreover, the course of gravity affected the expression degree of SLCO2A1, buttressing the discovering that its expression was affected by gravity. These outcomes recommend {that a} meta-analysis of DNA microarray datasets might assist establish new goal genes beforehand missed in particular person microarray analyses.
